ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

New Mammography Guidelines Cut Uses By Women Under 50 t 25%

July 29, 1977

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003